About company

Neurophyxia's main objective is to develop 2-iminobiotin (or 2-IB) as a novel injectable pharmaceutical product to reduce the deleterious effects of oxygen shortage in the brain occurring in two life-threatening conditions:

BE
Unknown
Not verified company